Testing the Toxicofera: comparative reptile transcriptomics casts doubt on the single, early evolution of the reptile venom system by Hargreaves, A.D. et al.
  
 
P
R
IF
Y
S
G
O
L
 B
A
N
G
O
R
 /
 B
A
N
G
O
R
 U
N
IV
E
R
S
IT
Y
 
 
Testing the Toxicofera: comparative reptile transcriptomics casts doubt on
the single, early evolution of the reptile venom system
Hargreaves, A.D.; Swain, M.T.; Logan, D.W.; Mulley, J.F.
Toxicon
DOI:
10.1016/j.toxicon.2014.10.004
Published: 17/10/2014
Peer reviewed version
Cyswllt i'r cyhoeddiad / Link to publication
Dyfyniad o'r fersiwn a gyhoeddwyd / Citation for published version (APA):
Hargreaves, A. D., Swain, M. T., Logan, D. W., & Mulley, J. F. (2014). Testing the Toxicofera:
comparative reptile transcriptomics casts doubt on the single, early evolution of the reptile
venom system. Toxicon, 92, 140-156. https://doi.org/10.1016/j.toxicon.2014.10.004
Hawliau Cyffredinol / General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or
other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal
requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private
study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to
the work immediately and investigate your claim.
 22. Jun. 2020
1 
 
Title page 1 
 2 
Title: 3 
Testing the Toxicofera: comparative transcriptomics casts doubt on the single, early evolution 4 
of the reptile venom system  5 
 6 
Authors: 7 
Adam D Hargreaves1, Martin T Swain2, Darren W Logan3 and John F Mulley1* 8 
 9 
Affiliations: 10 
1. School of Biological Sciences, Bangor University, Brambell Building, Deiniol Road, 11 
Bangor, Gwynedd, LL57 2UW, United Kingdom 12 
 13 
2. Institute of Biological, Environmental & Rural Sciences, Aberystwyth University, 14 
Penglais, Aberystwyth, Ceredigion, SY23 3DA, United Kingdom 15 
 16 
3. Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1HH, United Kingdom 17 
 18 
*To whom correspondence should be addressed: j.mulley@bangor.ac.uk 19 
 20 
 21 
Author email addresses: 22 
John Mulley - j.mulley@bangor.ac.uk 23 
Adam Hargreaves – adamdhargreaves@gmail.com 24 
Darren Logan - dl5@sanger.ac.uk 25 
Martin Swain - mts11@aber.ac.uk 26 
2 
 
Abstract  27 
The identification of apparently conserved gene complements in the venom and salivary 28 
glands of a diverse set of reptiles led to the development of the Toxicofera hypothesis – the 29 
single, early evolution of the venom system in reptiles. However, this hypothesis is based 30 
largely on relatively small scale EST-based studies of only venom or salivary glands and 31 
toxic effects have been assigned to only some putative Toxicoferan toxins in some species. 32 
We set out to examine the distribution of these proposed venom toxin transcripts in order to 33 
investigate to what extent conservation of gene complements may reflect a bias in previous 34 
sampling efforts. Our quantitative transcriptomic analyses of venom and salivary glands and 35 
other body tissues in five species of reptile, together with the use of available RNA-Seq 36 
datasets for additional species, shows that the majority of genes used to support the 37 
establishment and expansion of the Toxicofera are in fact expressed in multiple body tissues 38 
and most likely represent general maintenance or “housekeeping” genes. The apparent 39 
conservation of gene complements across the Toxicofera therefore reflects an artefact of 40 
incomplete tissue sampling. We therefore conclude that venom has evolved multiple times in 41 
reptiles.  42 
 43 
Keywords 44 
Snake venom, Toxicofera, Transcriptomics 45 
 46 
1. Introduction 47 
Snake venom is frequently cited as being highly complex or diverse (Li et al., 2005; Wagstaff 48 
et al., 2006; Kini and Doley, 2010) and a large number of venom toxin genes and gene 49 
families have been identified, predominantly from EST-based studies of gene expression 50 
during the re-synthesis of venom in the venom glands following manually-induced emptying 51 
(“milking”) of extracted venom (Pahari et al., 2007; Casewell et al., 2009; Siang et al., 2010; 52 
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Rokyta et al., 2011; Rokyta et al., 2012). It has been suggested that many of these gene 53 
families originated via the duplication of a gene encoding a non-venom protein expressed 54 
elsewhere in the body, followed by recruitment into the venom gland where natural selection 55 
could act to increase toxicity. Subsequent additional duplications would then lead to a 56 
diversification within gene families, often in a species-specific manner (Fry, 2005; Wong and 57 
Belov, 2012; Casewell et al., 2013). However, since whole genome duplication is a rare event 58 
in reptiles (Otto and Whitton, 2000), the hypothesis that novelty in venom originates via the 59 
duplication of a “body” gene with subsequent recruitment into the venom gland requires that 60 
gene duplication is a frequent event in the germline of venomous snakes. An additional 61 
prerequisite is that the promoter and enhancer sequences that regulate venom gland-specific 62 
expression are relatively simple and easy to evolve. It also suggests a high incidence of 63 
neofunctionalisation rather than the more common process of subfunctionalisation (Lynch 64 
and Force, 2000; Walsh, 2003; Lynch, 2007; Teshima and Innan, 2008). However, it has 65 
recently been shown that in fact snake venom toxins are likely derived from pre-existing 66 
salivary proteins that have been restricted to the venom gland rather than body proteins that 67 
have been recruited (Hargreaves et al. 2014a).  68 
The apparent widespread distribution of genes known to encode venom toxins in snakes in 69 
the salivary glands of a diverse set of reptiles, (including both those that had previously been 70 
suggested to have secondarily lost venom in favour of constriction or other predation 71 
techniques, and those that had previously been considered to have never been venomous), led 72 
to the development of the Toxicofera hypothesis – the single, early evolution of venom in 73 
reptiles (Vidal and Hedges, 2005; Fry et al., 2006; Fry et al., 2009a; Fry et al., 2012a) (Figure 74 
1). Analysis of a wide range of reptiles, including charismatic megafauna such as the 75 
Komodo dragon, Varanus komodoensis (Fry et al., 2009b), has shown that the ancestral 76 
Toxicoferan venom system comprises at least 16 genes, with additional gene families 77 
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subsequently recruited in different lineages (Fry et al., 2009a; Fry et al., 2012a; Fry et al., 78 
2013). 79 
Although toxic effects have been putatively assigned to some Toxicoferan venom proteins in 80 
certain species, the problem remains that their identification as venom components is based 81 
largely on their expression in the venom gland during venom synthesis and their apparent 82 
relatedness to other, known toxins in phylogenetic trees. It has long been known that all 83 
tissues express a basic set of “housekeeping” or maintenance genes (Butte et al., 2002) and it 84 
is therefore not surprising that similar genes might be found to be expressed in similar tissues 85 
in different species of reptiles, and that these genes might group together in phylogenetic 86 
trees. However, the identification of transcripts encoding putative venom toxins in other body 87 
tissues would cast doubt on the classification of these Toxicoferan toxins as venom 88 
components, as it is unlikely that the same gene could fulfil toxic and non-toxic (pleiotropic) 89 
roles without evidence for alternative splicing to produce a toxic variant (as has been 90 
suggested for acetylcholinesterase in the banded krait, Bungarus fasciatus (Vonk et al., 2011; 91 
Casewell et al., 2013)) or increased expression levels in the venom gland (where toxicity 92 
might be dosage dependent). In order to address some of these issues and to test the 93 
robustness of the Toxicofera hypothesis, we have carried out a comparative transcriptomic 94 
survey of the venom or salivary glands, skin and cloacal scent glands of five species of 95 
reptile. Unlike the pancreas and other parts of the digestive system (Strydom, 1973; Kochva, 96 
1987), these latter tissues (which include a secretory glandular tissue (the scent gland) and a 97 
relatively inert, non-secretory tissue (skin)) have not previously been suggested to be the 98 
source of duplicated venom toxin genes and we would therefore only expect to find 99 
ubiquitous maintenance or “housekeeping” genes to be commonly expressed across these 100 
tissues. We use the general term ‘salivary gland’ for simplicity, to encompass the oral glands 101 
of the leopard gecko and rictal glands and Duvernoy’s gland of the royal python, corn snake 102 
and rough green snake and do not imply any homology to mammalian salivary glands. 103 
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Our study species included the venomous painted saw-scaled viper (Echis coloratus); the 104 
non-venomous corn snake (Pantherophis guttatus) and rough green snake (Opheodrys 105 
aestivus) and a member of one of the more basal extant snake lineages, the royal python 106 
(Python regius). As members of the Toxicofera sensu Fry et al. (Fry et al., 2013) we would 107 
expect to find the basic Toxicoferan venom genes expressed in the venom or salivary glands 108 
of all of these species. In addition, we generated corresponding data for the leopard gecko 109 
(Eublepharis macularius), a member of one of the most basal lineages of squamate reptiles 110 
that lies outside of the proposed Toxicofera clade (Figure 1). We have also taken advantage 111 
of available transcriptomes or RNA-Seq data for corn snake vomeronasal organ 112 
(Brykczynska et al., 2013) and brain (Tzika et al., 2011), garter snake (Thamnophis elegans) 113 
liver (Schwartz and Bronikowski, 2013) and pooled tissues (brain, gonads, heart, kidney, 114 
liver, spleen and blood of males and females (Schwartz et al., 2010)), Eastern diamondback 115 
rattlesnake (Crotalus adamanteus) and eastern coral snake (Micrurus fulvius) venom glands 116 
(Rokyta et al., 2011; Rokyta et al., 2012; Margres et al., 2013), king cobra (Ophiophagus 117 
hannah) venom gland, accessory gland and pooled tissues (heart, lung, spleen, brain, testes, 118 
gall bladder, pancreas, small intestine, kidney, liver, eye, tongue and stomach) (Vonk et al., 119 
2013), Burmese python (Python molurus) pooled liver and heart (Castoe et al., 2011), green 120 
anole (Anolis carolinensis) pooled tissue (liver, tongue, gallbladder, spleen, heart, kidney and 121 
lung), testis and ovary (Eckalbar et al., 2013) and bearded dragon (Pogona vitticeps), Nile 122 
crocodile (Crocodylus niloticus) and chicken (Gallus gallus) brains (Tzika et al., 2011), as 123 
well as whole genome sequences for the Burmese python and king cobra (Castoe et al., 2013; 124 
Vonk et al., 2013). 125 
Assembled transcriptomes were searched for genes previously suggested to be venom toxins 126 
in Echis coloratus and related species (Wagstaff and Harrison, 2006; Casewell et al., 2009; 127 
Wagstaff et al., 2009) as well as those that have been used to support the Toxicofera 128 
hypothesis, namely acetylcholinesterase, AVIT peptide (Fry, 2005; Fry et al., 2009a; Vonk et 129 
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al., 2011; Fry et al., 2012a; Casewell et al., 2013), complement c3/cobra venom factor, 130 
epididymal secretory protein (Alper and Balavitch, 1976; Fry et al., 2012a), c-type lectins 131 
(Morita, 2005; Ogawa et al., 2005), cysteine-rich secretory protein (crisp) (Yamazaki et al., 132 
2003a; Yamazaki and Morita, 2004), crotamine (Rádis-Baptista et al., 2003; Oguiura et al., 133 
2005), cystatin (Ritonja et al., 1987; Richards et al., 2011), dipeptidylpeptidase, lysosomal 134 
acid lipase, renin aspartate protease (Wagstaff and Harrison, 2006; Aird, 2008; Casewell et 135 
al., 2009; Fry et al., 2012a), hyaluronidase (Tu and Hendon, 1983; Harrison et al., 2007), 136 
kallikrein (Komori et al., 1988; Komori and Nikai, 1998), kunitz (Župunski et al., 2003), l-137 
amino-acid oxidase (Suhr and Kim, 1996; Du and Clemetson, 2002), nerve growth factor 138 
(Angeletti, 1970; Kostiza and Meier, 1996), phospholipase A2 (Lynch, 2007), phospholipase 139 
b (Bernheimer et al., 1987; Chatrath et al., 2011; Rokyta et al., 2011), ribonuclease (Aird, 140 
2005), serine protease (Pirkle, 1998; Serrano and Maroun, 2005), snake venom 141 
metalloproteinase (Bjarnason and Fox, 1994; Jia et al., 1996), vascular endothelial growth 142 
factor (vegf) (Junqueira de Azevedo et al., 2001; Yamazaki et al., 2003b; Fry, 2005; Fry et 143 
al., 2006), veficolin (OmPraba et al., 2010), vespryn, waprin (Torres et al., 2003; Pung et al., 144 
2006; Nair et al., 2007; Fry et al., 2012a) and 3-finger toxins (Fry et al., 2003). Transcript 145 
abundance estimation values were also calculated to allow the identification of any potential 146 
occurrences of pleiotropy (a gene fulfilling a toxic and non-toxic role simultaneously) based 147 
upon an elevated expression level in the venom or salivary gland compared to other body 148 
tissues. All Transcript abundance values are given in FPKM (Fragments Per Kilobase of exon 149 
per Million fragments mapped) and are mean values to account for variation between 150 
individual samples (further details given in the methods section).  151 
We find that many genes previously claimed to be venom toxins are in fact expressed in 152 
multiple tissues (Figure 2) and that transcripts encoding these genes show no evidence of 153 
consistently elevated expression level in venom or salivary glands compared to other tissues 154 
(Supplemental tables S5-S9). Only two putative venom toxin genes (l-amino acid oxidase b2 155 
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and PLA2 IIA-c) showed evidence of a venom gland-specific splice variant across our 156 
multiple tissue data sets. We have also identified several cases of mistaken identity, where 157 
non-orthologous genes have been used to claim conserved, ancestral expression and instances 158 
of identical sequences being annotated as two distinct genes (see later sections). We propose 159 
that the putative ancestral Toxicoferan venom toxin genes do not encode toxic venom 160 
components in the majority of species and that the apparent venom gland-specificity of these 161 
genes is a side-effect of incomplete tissue sampling. Our analyses show that neither increased 162 
expression in the venom gland nor the production of venom-specific splice variants can be 163 
used to support continued claims for the toxicity of these genes.  164 
 165 
2. Methods 166 
Experimental methods involving animals followed institutional and national guidelines and 167 
were approved by the Bangor University Ethical Review Committee.  168 
2.1 RNA-Seq 169 
Total RNA was extracted from four venom glands taken from four individual specimens of 170 
adult Saw-scaled vipers (Echis coloratus) at different time points following venom extraction 171 
in order to capture the full diversity of venom genes (16, 24 and 48 hours post-milking).  172 
Additionally, total RNA from two scent glands and two skin samples of this species and the 173 
salivary, scent glands and skin of two adult corn snakes (Pantherophis guttatus), rough green 174 
snakes (Opheodrys aestivus), royal pythons (Python regius) and leopard geckos (Eublepharis 175 
macularius) was also extracted using the RNeasy mini kit (Qiagen) with on-column DNase 176 
digestion. Only a single corn snake skin sample provided RNA of high enough quality for 177 
sequencing. mRNA was prepared for sequencing using the TruSeq RNA sample preparation 178 
kit (Illumina) with a selected fragment size of 200-500bp and sequenced using 100bp paired-179 
end reads on the Illumina HiSeq2000 or HiSeq2500 platform.  180 
2.2 Quality control, assembly and analysis 181 
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The quality of all raw sequence data was assessed using FastQC (Andrews, 2010) and reads 182 
for each tissue and species were pooled and assembled using Trinity (Grabherr et al., 2011) 183 
(sequence and assembly metrics are provided in Supplemental tables S1-S3). Putative venom 184 
toxin amino acid sequences were aligned using ClustalW (Larkin et al., 2007) and maximum 185 
likelihood trees constructed using the Jones-Taylor-Thornton (JTT) model with 500 186 
Bootstrap replicates. Transcript abundance estimation was carried out using RSEM (Li and 187 
Dewey, 2011) as a downstream analysis of Trinity (version trinityrnaseq_r2012-04-27). Sets 188 
of reads were mapped to species-specific reference transcriptome assemblies (Supplementary 189 
table S4) to allow comparison between tissues on a per-species basis and all results values 190 
shown are in FPKM (Fragments Per Kilobase of exon per Million fragments mapped). 191 
Individual and mean FPKM values for each gene per tissue per species are given in 192 
Supplementary tables S5-S9. All transcript abundance values given within the text are based 193 
on the average transcript abundance per tissue per species to account for variation between 194 
individual samples. 195 
Transcriptome reads were deposited in the European Nucleotide Archive (ENA) database 196 
under accession #ERP001222 and GenBank under the run accession numbers SRR1287707 197 
and SRR1287715. Genes used to reconstruct phylogenies are deposited in GenBank under the 198 
BioProject accession number PRJNA255316. 199 
 200 
 201 
3. Results 202 
3.1 Genes unlikely to represent toxic components of the Toxicofera 203 
Based on our quantitative analysis of their expression pattern across multiple species, we 204 
identify the following genes as unlikely to represent toxic venom components in the 205 
Toxicofera clade (Vidal and Hedges, 2005). The identification of these genes as non-venom 206 
is more parsimonious than alternative explanations such as the reverse recruitment of a 207 
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“venom” gene back to a “body” gene (Casewell et al., 2012), which requires a far greater 208 
number of steps (duplication, recruitment, selection for increased toxicity, reverse 209 
recruitment) to have occurred in each species, whereas a “body” protein remaining a “body” 210 
protein is a zero-step process regardless of the number of species involved. The process of 211 
reverse recruitment must also be considered doubtful given the rarity of gene duplication in 212 
vertebrates (estimated to be between 1 gene per 100 to 1 gene per 1000 per million years 213 
(Cotton and Page, 2005; Lynch and Conery, 2000; Lynch and Conery, 2003)). 214 
3.1.1 Acetylcholinesterase 215 
We find identical acetylcholinesterase (ache) transcripts in the E. coloratus venom gland and 216 
scent gland (which we call transcript 1) and an additional splice variant expressed in skin and 217 
scent gland (transcript 2). Whilst the previously known splice variants in banded krait 218 
(Bungarus fasciatus) are differentiated by the inclusion of an alternative exon, analysis of the 219 
E. coloratus ache genomic sequence (accession number KF114031) reveals that the shorter 220 
transcript 2 instead comprises only the first exon of the ache gene, with a TAA stop codon 221 
that overlaps the 5’ GT dinucleotide splice site in intron 1.  ache transcript 1 is expressed at a 222 
low level in the venom gland (6.60 FPKM) and is found in multiple tissues in all study 223 
species (Figure 2), as well as corn snake vomeronasal organ and garter snake liver. The 224 
shorter transcript 2 is found most often in skin and scent glands (Figure 2, Supplementary 225 
figure S1). The low expression level and diverse tissue distribution of transcripts of this gene 226 
suggest that acetylcholinesterase does not represent a Toxicoferan venom toxin. Whilst some 227 
ACHE activity has been recorded in the oral secretions of a number of colubrid snakes 228 
(Mackessy, 2002), experiments with these secretions shows that several hours are needed to 229 
achieve complete neuromuscular blockage. It should also be noted that the most frequently 230 
cited sources for the generation of a toxic version of ache in banded krait via alternative 231 
splicing include statements that ache “does not appear to contribute to the toxicity of the 232 
venom” (Cousin et al., 1998), is “not toxic to mice, even at very high doses” (Cousin et al., 233 
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1996a) and is “neither toxic by itself nor acting in a synergistic manner with the toxic 234 
components of venom” (Cousin et al., 1996b).  235 
3.1.2 AVIT   236 
We find only a single transcript encoding an AVIT peptide in our dataset, in the scent gland 237 
of the rough green snake (data not shown). The absence of this gene in all of our venom and 238 
salivary gland datasets, as well as the venom glands of the king cobra, eastern coral snake and 239 
Eastern diamondback rattlesnake, and the limited number of sequences available on Genbank 240 
(one species of snake, Dendroaspis polylepis (accession number P25687) and two species of 241 
lizard, Varanus varius and Varanus komodoensis (accession numbers AAZ75583 and 242 
ABY89668 respectively)) despite extensive sampling, would suggest that it is unlikely to 243 
represent a conserved Toxicoferan venom toxin. 244 
3.1.3 Complement C3 (“cobra venom factor”) 245 
We find identical transcripts encoding complement c3 in all tissues in all species, with the 246 
exception of royal python skin (Figures 2 and 3) and we find only a single complement c3 247 
gene in the E. coloratus genome (data not shown). These findings, together with the 248 
identification of transcripts encoding this gene in the liver, brain, vomeronasal organ and 249 
tissue pools of various other reptile species (Figure 3) demonstrate that this gene does not 250 
represent a Toxicoferan venom toxin. However, the grouping of additional complement c3 251 
genes in the king cobra (Ophiophagus hannah) and monocled cobra (Naja kaouthia) in our 252 
phylogenetic tree does support a duplication of this gene somewhere in the Elapid lineage. 253 
One of these paralogs may therefore represent a venom toxin in at least some of these more 254 
derived species and the slightly elevated expression level of this gene in the venom or 255 
salivary gland of some of our study species suggests that complement c3 has been exapted 256 
(Gould and Vrba, 1982) to become a venom toxin in the Elapids. It seems likely that the 257 
identification of the non-toxic paralog in other species (including veiled chameleon 258 
(Chamaeleo calyptratus), spiny-tailed lizard (Uromastyx aegyptia) and Mitchell's water 259 
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monitor (Varanus mitchelli)) has contributed to confusion about the distribution of this 260 
“Cobra venom factor” (which should more rightly be called complement c3b), to the point 261 
where genes in alligator (Alligator sinensis), turtles (Pelodiscus sinensis) and birds (Columba 262 
livia) are now being annotated as venom factors (accession numbers XP 006023407-8, XP 263 
006114685, XP 005513793, Figure 3). 264 
3.1.4 Cystatin  265 
We find two transcripts encoding cystatins expressed in the venom gland of E. coloratus 266 
corresponding to cystatin-e/m and f (Supplementary figures S2 and S3). cystatin-e/m was 267 
found to be expressed in all tissues from all species used in this study (Figure 2), as well as 268 
corn snake vomeronasal organ and brain and garter snake liver and pooled tissues. The 269 
transcript encoding cystatin-f (which has not previously been reported to be expressed in a 270 
snake venom gland) is also expressed in the scent gland of E. coloratus and in the majority of 271 
other tissues of our study species. We find no evidence for a monophyletic clade of 272 
Toxicoferan cystatin-derived venom toxins and would agree with Richards et al. (Richards et 273 
al., 2011) that low expression level and absence of in vitro toxicity represents a “strong case 274 
for snake venom cystatins as essential housekeeping or regulatory proteins, rather than 275 
specific prey-targeted toxins…” Indeed, it is unclear why cystatins should be considered to be 276 
conserved venom toxins, since even the original discovery of cystatin in the venom of the 277 
puff adder (Bitis arietans) states that there is “…no evidence that it is connected to the 278 
toxicity of the venom” (Ritonja et al., 1987). 279 
3.1.5 Dipeptidyl peptidases 280 
We find identical transcripts encoding dipeptidyl peptidase 3 and 4 in all tissues in all species 281 
except the leopard gecko (Figures 2, 4a and 4b), and both of these have a low transcript 282 
abundance in the venom gland of E. coloratus. dpp4 is expressed in garter snake liver and 283 
Anole testis and ovary and dpp3 is also expressed in garter snake liver, king cobra pooled 284 
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tissues and Bearded dragon brain (Figures 4a and b). It is therefore unlikely the either dpp3 or 285 
dpp4 represent venom toxins. 286 
3.1.6 Epididymal secretory protein 287 
We find one transcript encoding epididymal secretory protein (ESP) expressed in the venom 288 
gland of Echis coloratus (9.09 FPKM) corresponding to type E1. This transcript is also found 289 
to be expressed at similar levels in the scent gland (13.71 FPKM) and skin (8.64 FPKM) of 290 
this species and orthologous transcripts are expressed in all three tissues of all other species 291 
used in this study (Figure 2 and Supplementary figure S4a), suggesting that this is a 292 
ubiquitously expressed gene and not a venom component. Previously described epididymal 293 
secretory protein sequences from varanids (Fry et al., 2010) and the colubrid Cylindrophis 294 
ruffus (Fry et al., 2013) do not represent esp-e1 and their true orthology is currently unclear. 295 
However, our analysis of these and related sequences suggests that they are likely part of a 296 
reptile-specific expansion of esp-like genes and that the Varanus and Cylindrophis sequences 297 
do not encode the same gene (Supplementary figure S4b). Therefore there is not, nor was 298 
there ever, any evidence that epididymal secretory protein sequences represent venom 299 
components in the Toxicofera. 300 
3.1.7 Ficolin (“veficolin”) 301 
We find one transcript encoding ficolin in the E. coloratus venom gland and identical 302 
transcripts in both scent gland and skin (Figure 2, Supplementary figure S5) and orthologous 303 
transcripts in all corn snake and leopard gecko tissues, as well as rough green snake salivary 304 
and scent glands and royal python salivary gland. Paralogous genes expressed in multiple 305 
tissues were also found in corn snake and rough green snake (Supplementary figure S5). 306 
These findings, together with additional data from available transcriptomes of pooled garter 307 
snake body tissues and bearded dragon and chicken brains show that ficolin does not 308 
represent a Toxicoferan venom component. 309 
3.1.8 Hyaluronidase  310 
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Hyaluronidase has been suggested to be a “venom spreading factor” to aid the dispersion of 311 
venom toxins throughout the body of envenomed prey, and as such it does not represent a 312 
venom toxin itself (Kemparaju and Girish, 2006). We do however find two hyaluronidase 313 
genes expressed in the venom gland of E. coloratus. The first appears to be venom gland 314 
specific (based on available data) and has two splice variants including a truncated variant 315 
similar to sequences previously characterised from Echis carinatus sochureki (accession 316 
number DQ840262) and Echis pyramidum leakeyi (accession number DQ840255) venom 317 
glands (Harrison et al., 2007). Although we cannot rule out hyaluronidase playing an active 318 
(but non-toxic) role in Echis venom, it is worth commenting that hyaluronan has been 319 
suggested to have a role in wound healing and the protection of the oral mucosa in human 320 
saliva (Pogrel et al., 2003). The expression of hyaluronidases involved in hyaluronan 321 
metabolism in venom and/or salivary glands is therefore perhaps unsurprising. 322 
3.1.9 Kallikrein 323 
We find two Kallikrein-like sequences in E. coloratus, one of which is expressed in all three 324 
tissues in this species (at a low level in the venom gland) and a variety of other tissues in the 325 
other study species, and one of which is found only in scent gland and skin (Figure 2, 326 
Supplementary figure S6). These genes do not represent venom toxins in E. coloratus and 327 
appear to be most closely-related to a group of mammalian Kallikrein (KLK) genes 328 
containing KLK1, 11, 14 and 15 and probably represent the outgroup to a mammalian-329 
specific expansion of this gene family. The orthology of previously published Toxicoferan 330 
Kallikrein genes is currently unclear and the majority of these sequences can be found in our 331 
serine protease tree (see later section and Supplementary figure S19). 332 
3.1.10 Kunitz 333 
We find a number of transcripts encoding Kunitz-type protease inhibitors in our tissue data, 334 
with the majority of these encoding kunitz1 and kunitz2 genes (Figure 2 and Supplementary 335 
figure S7). The tissue distribution of these transcripts, together with the phylogenetic position 336 
14 
 
of lizard and venomous snake sequences does not support a monophyletic clade of venom 337 
gland-specific Kunitz-type genes in the Toxicofera. The presence of protease inhibitors in 338 
reptile venom and salivary glands should perhaps not be too surprising and it again seems 339 
likely that the involvement of Kunitz-type inhibitors in venom toxicity in some advanced 340 
snake lineages (in this case mamba (Dendroaspis spp.) dendrotoxins and krait (Bungarus 341 
multicinctus) bungarotoxins (Harvey, 2001; Kwong et al., 1995)) has led to confusion when 342 
non-toxic orthologs have been identified in other species. 343 
3.1.11 Lysosomal acid lipase  344 
We find two transcripts encoding Lysosomal acid lipase genes in the E. coloratus venom 345 
gland transcriptome, one of which (lipa-a) is also expressed in skin and scent gland in this 346 
species and all three tissues in our other study species. lipa-a, despite not being venom gland 347 
specific, is more highly expressed in the venom gland (3,337.33 FPKM) than in the scent 348 
gland (484.49 FPKM) and skin (22.79 FPKM) of E. coloratus, although there is no evidence 349 
of elevated expression in the salivary glands of our other study species. As this protein is 350 
involved in lysosomal lipid hydrolysis (Warner et al., 1981) and the venom gland is a highly 351 
active tissue, we suggest that this elevated expression is likely related to high cell turnover. 352 
Transcripts of lipa-b are found at a low level in the venom and scent glands of E. coloratus 353 
and the scent gland of royal python (Figure 2, Supplementary figure S8). Neither lipa-a or 354 
lipa-b therefore encode venom toxins.  355 
3.1.12 Natriuretic peptide 356 
We find only a single natriuretic peptide-like sequence in our dataset, in the skin of the royal 357 
python. The absence of this gene from the rest of our study species suggests that it is not a 358 
highly conserved Toxicoferan toxin. 359 
3.1.13 Nerve growth factor 360 
We find identical transcripts encoding nerve growth factor (ngf) in all three E. coloratus 361 
tissues. Transcripts encoding the orthologous  gene are also found in the corn snake salivary 362 
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gland and scent gland; rough green snake scent gland and skin; royal python skin and leopard 363 
gecko salivary gland, scent gland and skin (Figure 2 and Supplementary figure S9). ngf is 364 
expressed at a higher level in the venom gland (525.82 FPKM) than in the scent gland (0.18 365 
FPKM) and skin (0.58 FPKM) of E. coloratus, but not at an elevated level in the salivary 366 
gland of other species, again hinting at the potential for exaptation of this gene. Based on 367 
these findings, together with the expression of this gene in garter snake pooled tissues, we 368 
suggest that ngf does not encode a Toxicoferan toxin. However, we do find evidence for the 369 
duplication of ngf in cobras (Supplementary figure S9), suggesting that it may represent a 370 
venom toxin in at least some advanced snakes (Sunagar et al., 2013). As with complement c3, 371 
it seems likely that the identification of non-toxic orthologs in distantly-related species has 372 
led to the conclusion that ngf is a widely-distributed venom toxin and confused its true 373 
evolutionary history. 374 
3.1.14 Phospholipase A2 (PLA2 Group IIE) 375 
We find transcripts encoding Group IIE PLA2 genes in the venom gland of E. coloratus and 376 
the salivary glands of all other species (Figure 2, Supplementary figure S10). Although this 377 
gene appears to be venom and salivary-gland-specific (based on available data), its presence 378 
in all species (including the non-Toxicoferan leopard gecko) suggests that it does not 379 
represent a toxic venom component. 380 
3.1.15 Phospholipase B 381 
We find a single transcript encoding phospholipase b expressed in all three E. coloratus 382 
tissues (Figures 2 and 5) and transcripts encoding the orthologous gene are found in all other 383 
tissues from all study species, with the exception of rough green snake salivary gland. We 384 
also find plb transcripts in corn snake vomeronasal organ, garter snake liver, Burmese python 385 
pooled tissues (liver and heart) and bearded dragon brain (Figure 5). The two transcripts in 386 
the rough green snake and corn snake are likely alleles or the result of individual variation, 387 
and actually represent a single phospholipase b gene from each of these species. Transcript 388 
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abundance analysis shows this gene to be expressed at a low level in all tissues from all study 389 
species. Based on the phylogenetic and tissue distribution of this gene it is unlikely to 390 
represent a Toxicoferan venom toxin. 391 
3.1.16 Renin (“renin aspartate protease”)  392 
We find a number of transcripts encoding renin-like genes in the E. coloratus venom gland 393 
(Figures 2 and 6), one of which (encoding the canonical renin) is also expressed in the scent 394 
gland and is orthologous to a previously described sequence from the venom gland of the 395 
ocellated carpet viper (Echis ocellatus, accession number CAJ55260). We also find that the 396 
recently-published Boa constrictor renin aspartate protease (rap) gene (accession number 397 
JX467165 (Fry et al., 2013)) is in fact a cathepsin d gene, transcripts of which are found in all 398 
three tissues in all five of our study species. We suggest that this misidentification may be 399 
due to a reliance on BLAST-based classification, most likely using a database restricted to 400 
squamate or serpent sequences. It is highly unlikely that either renin or cathepsin d (or indeed 401 
any renin-like aspartate proteases) constitute venom toxins in E. coloratus or E. ocellatus, nor 402 
do they represent basal Toxicoferan toxins. 403 
3.1.17 Ribonuclease 404 
Ribonucleases have been suggested to have a role in the generation of free purines in snake 405 
venoms (Aird, 2005) and the presence of these genes in the salivary glands of two species of 406 
lizard (Gerrhonotus infernalis and Celestus warreni) and two colubrid snakes (Liophis 407 
peocilogyrus and Psammophis mossambicus) has been used to support the Toxicofera (Fry et 408 
al., 2010; Fry et al., 2012b). We did not identify orthologous ribonuclease genes in any of our 409 
salivary or venom gland data, nor do we find them in venom gland transcriptomes from the 410 
Eastern diamondback rattlesnake, king cobra and eastern coral snake (although we have 411 
identified a wide variety of other ribonuclease genes). The absence of these genes in seven 412 
Toxicoferans, coupled with the fact that they were initially described from only 2 out of 11 413 
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species of snake (Fry et al., 2012b) and 3 out of 18 species of lizard (Fry et al., 2010) would 414 
cast doubt on their status as conserved Toxicoferan toxins.  415 
3.1.18 Three finger toxins (3ftx) 416 
We find 2 transcripts encoding three finger toxin (3ftx)-like genes expressed in the E. 417 
coloratus venom gland, one of which is expressed in all 3 tissues (3ftx-a) whilst the other is 418 
expressed in the venom and scent glands (3ftx-b). Orthologous transcripts of 3ftx-a are found 419 
to be expressed in all three tissues of corn snake, rough green snake salivary gland and skin, 420 
and royal python salivary gland. An ortholog of 3ftx-b is expressed in rough green snake 421 
scent gland. We also find a number of different putative 3ftx genes in our other study species, 422 
often expressed in multiple tissues (Figure 2, Supplementary figure S11). Based on the 423 
phylogenetic and tissue distribution of both of these genes we suggest that they do not 424 
represent venom toxins in E. coloratus. As with other proposed Toxicoferan genes such as 425 
complement c3 and nerve growth factor, it seems likely that 3ftx genes are indeed venom 426 
components in some species, especially cobras and other elapids (Vonk et al., 2013; Fry et 427 
al., 2003), and that the identification of their non-venom orthologs in other species has led to 428 
much confusion regarding the phylogenetic distribution of these toxic variants.  429 
3.1.19 Vespryn 430 
We do not find vespryn transcripts in any E. coloratus tissues, although this gene is present in 431 
the genome of this species (accession number KF114032). We do however find transcripts 432 
encoding this gene in the salivary and scent glands of the corn snake, and skin and scent glands 433 
of the rough green snake, royal python and leopard gecko (Figure 2, Supplementary figure 434 
S12). We suggest that the tissue distribution of this gene in these species casts doubt on its role 435 
as a venom component in the Toxicofera.  436 
3.1.20 Waprin  437 
We find a number of “waprin”-like genes in our dataset, expressed in a diverse array of body 438 
tissues. Our phylogenetic analyses (Supplementary figure S13) show that previously 439 
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characterised “waprin” genes (Torres et al., 2003; Fry et al., 2008; Rokyta et al., 2012; Aird 440 
et al., 2013; Nair et al., 2007) most likely represent WAP four-disulfide core domain 2 441 
(wfdc2) genes, which have undergone a squamate-specific expansion for which there is no 442 
evidence for a venom gland-specific paralog. It is unlikely therefore that these genes 443 
represent a Toxicoferan venom toxin. Indeed, the inland taipan (Oxyuranus microlepidotus) 444 
“Omwaprin” has been shown to be “…non-toxic to Swiss albino mice at doses of up to 10 445 
mg/kg when administered intraperitoneally” (Nair et al., 2007) and is more likely to have an 446 
antimicrobial function in the venom or salivary gland. 447 
3.2 Putative venom toxins of Echis coloratus 448 
The following genes show either a venom gland-specific expression or an elevated expression 449 
level in this tissue, but not both. As such we suggest that whilst they may represent venom 450 
toxins in E. coloratus, further analysis is needed in order to confirm this. 451 
3.2.1 Vascular endothelial growth factor  452 
We find four transcripts encoding vascular endothelial growth factor (VEGF) expressed in the 453 
venom gland of E. coloratus. These correspond to vegf-a, vegf-b, vegf-c and vegf-f and of these, 454 
vegf-a, b and c are also expressed in the skin and scent gland of this species (Figure 2). 455 
Transcripts encoding orthologs of these genes are expressed in all three tissues of all other 456 
species used in this study (with the exception of the absence of vegf-a in corn snake skin). In 457 
accordance with previous studies (Rokyta et al., 2011), we find evidence of alternative splicing 458 
of vegf-a transcripts in all species although no variant appears to be tissue-specific. It is likely 459 
that a failure to properly recognise and classify alternatively spliced vegf-a transcripts (Aird et 460 
al., 2013) may have contributed to an overestimation of snake venom complexity. vegf-d was 461 
only found to be expressed in royal python salivary gland and scent gland and all three tissues 462 
from leopard gecko (Figure 2, Supplementary figure S14). The transcript encoding VEGF-F is 463 
found only in the venom gland of E. coloratus and, given the absence of any Elapid vegf-f 464 
sequences in public databases as well as absence of this transcript in the two species of colubrid 465 
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in our study, we suggest that vegf-f is specific to vipers. Whilst vegf-f has a higher transcript 466 
abundance in E. coloratus venom gland (186.73 FPKM) than vegf-a (3.24 FPKM), vegf-b (1.28 467 
FPKM) and vegf-c (1.54 FPKM), compared to other venom genes in this species (see next 468 
section) it has a considerably lower transcript abundance suggesting it represents at most a 469 
minor venom component in E. coloratus. 470 
3.2.2 L-amino acid oxidase  471 
We find transcripts encoding two l-amino acid oxidase (laao) genes in E. coloratus, one of 472 
which (laao-b) has two splice variants (Figure 2, Supplementary figure S15). laao-a 473 
transcripts are found in all three E. coloratus and leopard gecko tissues. laao-b is venom 474 
gland-specific in E. coloratus (based on the available data) and transcripts of the orthologous 475 
gene are found in the scent glands of corn snake, rough green snake and royal python. The 476 
splice variant laao-b2 may represent a venom toxin in E. coloratus based on its specific 477 
expression in the venom gland of this species and elevated expression level (628.84 FPKM). 478 
3.2.3 Crotamine 479 
We find a single crotamine-like transcript in the venom gland of E. coloratus (Figure 2). 480 
Related genes are found in a variety of tissues in other study species (including the scent 481 
gland of the rough green snake, the salivary gland and skin of the leopard gecko, and in all 482 
three corn snake tissues), although the short length of these sequences precludes a definitive 483 
statement of orthology. This gene may represent a toxic venom component in E. coloratus 484 
based on its tissue distribution, but due to its low transcript abundance (10.95 FPKM) it is 485 
likely to play a minor role, if any. 486 
3.3 Proposed venom toxins in Echis coloratus 487 
The following genes are found only in the venom gland of E. coloratus and clearly show an 488 
elevated expression level (Figure 7). Whilst we classify these genes as encoding venom 489 
toxins in this species (Table 1) it should be noted that none of these genes support the 490 
monophyly of Toxicoferan venom toxins. 491 
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3.3.1 Cysteine-rich secretory proteins (CRISPs) 492 
We find transcripts encoding two distinct CRISPs expressed in the E. coloratus venom gland, 493 
one of which is also found in skin and scent gland (Figure 2). Phylogenetic analysis of these 494 
genes (which we call crisp-a and crisp-b) reveals that they appear to have been created as a 495 
result of a gene duplication event earlier in the evolution of advanced snakes (Supplementary 496 
Figure S16). crisp-a transcripts are also found in all three corn snake tissues, as well as rough 497 
green snake skin and scent gland and royal python scent gland. crisp-b is also found in corn 498 
snake salivary gland (Figure 2 and Supplementary figure S16) and the phylogenetic and 499 
tissue distribution of this gene suggest that it does indeed represent a venom toxin, produced 500 
via duplication of an ancestral crisp gene that was expressed in multiple tissues, including the 501 
salivary gland. The elevated transcript abundance of crisp-b (3,520.07 FPKM) in the venom 502 
gland of E. coloratus further supports its role as a venom toxin in this species (Figure 7). The 503 
phylogenetic and tissue distribution and low transcript abundance of crisp-a (0.61 FPKM in 504 
E. coloratus venom gland) shows that it is unlikely to be a venom toxin. We also find no 505 
evidence of a monophyletic clade of reptile venom toxins and therefore suggest that, contrary 506 
to earlier reports (Fry et al., 2009b; Fry et al., 2010), the CRISP genes of varanid and 507 
helodermatid lizards do not represent shared Toxicoferan venom toxins and, if they are 508 
indeed toxic venom components, they have been recruited independently from those of the 509 
advanced snakes. Regardless of their status as venom toxins, it appears likely that the 510 
diversity of CRISP genes in varanid lizards in particular (Fry et al., 2006) has been 511 
overestimated as a result of the use of negligible levels of sequence variation to classify 512 
transcripts as representing distinct gene products (Supplementary figures S23 and S24). 513 
3.3.2 C-type lectins 514 
We find transcripts encoding 11 distinct C-type lectin genes in the E. coloratus venom gland, 515 
one of which (ctl-a) is also expressed in the scent gland of this species. The remaining 10 516 
genes (ctl-b to k) are found only in the venom gland and form a clade with other viper C-type 517 
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lectin genes (Figure 2, Supplementary figure S17). Of these, 6 are highly expressed in the 518 
venom gland (ctl-b to d, ctl-f to g and ctl-j) with a transcript abundance range of 3,706.21-519 
24,122.41 FPKM (Figure 7). The remainder of these genes (ctl-e, ctl-h to i and ctl-k) show 520 
lower transcript abundance (0.80-1,475.88 FPKM), with two (ctl-i and k) being more lowly 521 
expressed than ctl-a (230.06 FPKM). A number of different C-type lectin genes are found in 522 
our other study species, often expressed in multiple tissues (Supplementary figure S17). We 523 
therefore suggest that the 6 venom-gland specific C-type lectin genes that are highly 524 
expressed are indeed venom toxins in E. coloratus and that these genes diversified via the 525 
duplication of an ancestral gene with a wide expression pattern, including in salivary/venom 526 
glands. Based on their selective expression in the venom gland (from available data) the 527 
remaining four C-type lectin genes cannot be ruled out as putative toxins, although their 528 
lower transcript abundance suggests that they are likely to be minor components in E. 529 
coloratus venom. It should also be noted that a recent analysis of king cobra (Ophiohagus 530 
hannah) venom gland transcriptome and proteome suggested that “…lectins do not contribute 531 
to king cobra envenoming” (Vonk et al., 2013).  532 
3.3.3 Phospholipase A2 (PLA2 Group IIA) 533 
We find five transcripts encoding Group IIA PLA2 genes in E. coloratus, three of which are 534 
found only in the venom gland and two of which are found only in the scent gland (these 535 
latter two likely represent intra-individual variation in the same transcript) (Figure 2, 536 
Supplementary figure S18). The venom gland-specific transcript PLA2 IIA-c is highly 537 
expressed (22,520.41 FPKM) and likely represents a venom toxin, and may also be a putative 538 
splice variant although further analysis is needed to confirm this. PLA2 IIA-d and IIA-e show 539 
an elevated, but lower, expression level (1,677.15 FPKM and 434.67 FPKM respectively, 540 
Figure 7). Based on tissue and phylogenetic distribution we would propose that these three 541 
genes may represent putative venom toxins (Table 1).   542 
3.3.4 Serine proteases 543 
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We find 6 transcripts encoding Serine proteases in E. coloratus (Figure 2, Supplementary 544 
figure S19) which (based on available data) are all venom gland specific. Four of these 545 
transcripts are highly expressed in the venom gland (serine proteases a-c and e; 3,076.01-546 
7,687.03 FPKM) whilst two are expressed at a lower level (serine proteases d and f; 1,098.45 547 
FPKM and 102.34 FPKM respectively, Figure 7). Based on these results we suggest serine 548 
proteases a, b, c and e represent venom toxins whilst serine proteases d and f may represent 549 
putative venom toxins (Table 1). 550 
3.3.5 Snake venom metalloproteinases 551 
We find 21 transcripts encoding snake venom metalloproteinases in E. coloratus and of these 552 
14 are venom gland-specific, whilst another (svmp-n) is expressed in the venom gland and 553 
scent gland. Five remaining genes are expressed in the scent gland only whilst another is 554 
expressed in the skin (Figure 2, Supplementary figure S20). Of the 14 venom gland-specific 555 
SVMPs we find 4 to be highly expressed (5,552.84-15,118.41 FPKM, Figure 7). In the 556 
absence of additional data, we classify the 13 venom gland-specific svmp genes as venom 557 
toxins in this species (Table 1). 558 
4. Discussion 559 
Our transcriptomic analyses have revealed that all 16 of the basal venom toxin genes used to 560 
support the hypothesis of a single, early evolution of venom in reptiles (the Toxicofera 561 
hypothesis (Vidal and Hedges, 2005; Fry et al., 2006; Fry et al., 2009a; Fry et al., 2009b; Fry 562 
et al., 2010; Fry et al., 2012a; Fry et al., 2013)), as well as a number of other genes that have 563 
been proposed to encode venom toxins in multiple species are in fact expressed in multiple 564 
tissues, with no evidence for consistently higher expression in venom or salivary glands. 565 
Additionally, only two genes in our entire dataset of 74 genes in five species were found to 566 
encode possible venom gland-specific splice variants (l-amino acid oxidase b2 and PLA2 IIA-567 
c). We therefore suggest that many of the proposed basal Toxicoferan genes most likely 568 
represent housekeeping or maintenance genes and that the identification of these genes as 569 
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conserved venom toxins is a side-effect of incomplete tissue sampling. This lack of support 570 
for the Toxicofera hypothesis therefore prompts a return to the previously held view 571 
(Kardong et al., 2009) that venom in different lineages of reptiles has evolved independently, 572 
once at the base of the advanced snakes, once in the helodermatid (gila monster and beaded 573 
lizard) lineage and, possibly, one other time in monitor lizards, although evidence for a 574 
venom system in this latter group (Fry et al., 2009b; Fry et al., 2010; Vikrant and Verma, 575 
2013) may need to be reinvestigated in light of our findings. The process of reverse 576 
recruitment (Casewell et al., 2012), where a venom gene undergoes additional gene 577 
duplication events and is subsequently recruited from the venom gland back into a body 578 
tissue (which was proposed on the basis of the placement of garter snake and Burmese 579 
python “physiological” genes within clades of “venom” genes) must also be re-evaluated in 580 
light of our findings.  581 
Bites by venomous snakes are thought to be responsible for as many as 1,841,000 582 
envenomings and 94,000 deaths annually (predominantly in the developing world 583 
(Kasturiratne et al., 2008; Harrison et al., 2009)), and medical treatment of snakebite is reliant 584 
on the production of antivenoms containing antibodies, typically from sheep or horses, that 585 
will bind and neutralise toxic venom proteins (Chippaux and Goyffon, 1998). Since these 586 
antivenoms are derived from the injection of crude venom into the host animal, they are not 587 
targeted to the most pathogenic venom components and therefore also include antibodies to 588 
weakly- or non-pathogenic proteins requiring the administration of large or multiple doses 589 
(Casewell et al., 2013), increasing the risks of adverse reactions. A comprehensive 590 
understanding of snake venom composition is therefore vital for the development of the next 591 
generation of antivenoms (Harrison, 2004; Wagstaff et al., 2006; Casewell et al., 2013) as it 592 
is important that research effort is not spread too thinly through the inclusion of non-toxic 593 
venom gland transcripts. Our results suggest that erroneous assumptions about the single 594 
origination and functional conservation of venom toxins across the Toxicofera has led to the 595 
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complexity of snake venom being overestimated by previous authors. We propose that the 596 
venom of the painted saw-scaled viper, Echis coloratus, is likely to consist of just 34 genes in 597 
8 gene families (Table 1, based on venom gland-specific expression and a ‘high’ expression, 598 
as defined by presence in the top 25% of transcripts (Williford and Demuth, 2012) in at least 599 
two of four venom gland samples), fewer than has been suggested for this and related species 600 
in previous EST or transcriptomic studies (Wagstaff and Harrison, 2006; Casewell et al., 601 
2009).  602 
It is noteworthy that the results of our analyses accord well with proteomic analyses of 603 
venom composition in snakes, with an almost identical complement of 35 toxins in 8 gene 604 
families known from the related ocellated carpet viper, Echis ocellatus (Wagstaff et al., 605 
2009), where SVMPs, CTLs and PLA2s were found to be the most abundant proteins. Studies 606 
of a range of other venomous snake species have identified a typical complement of between 607 
24-61 toxins in 6-14 families (Table 2). Far from being a “complex cocktail” (Izidoro et al., 608 
2006; Calvete et al., 2007b; Wong and Belov, 2012; Casewell et al., 2013), snake venom may 609 
in fact represent a relatively simple mixture of toxic proteins honed by natural selection for 610 
rapid prey immobilisation, with limited lineage-specific expansion in one or a few particular 611 
gene families.  612 
In order to avoid continued overestimation of venom complexity, we propose that future 613 
transcriptome-based analyses of venom composition must include quantitative comparisons 614 
of multiple body tissues from multiple individuals and robust phylogenetic analysis that 615 
includes known paralogous members of gene families. We would also encourage the use of 616 
clearly explained, justifiable criteria for classifying highly similar sequences as new paralogs 617 
rather than alleles or the result of PCR or sequencing errors, as it seems likely that some 618 
available sequences from previous studies have been presented as distinct genes on the basis 619 
of extremely minor (or even non-existent) sequence variation (see Supplementary figures 620 
S21-S24 for examples of identical or nearly identical ribonuclease and CRISP sequences and 621 
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Supplementary figures S25 and S26 for examples of the same sequence being annotated as 622 
two different genes). As a result, the diversity of “venom” composition in these species may 623 
have been inadvertently inflated.  624 
Additionally, we would encourage the adoption of a standard nomenclature for reptile genes, 625 
as the overly-complicated and confusing nomenclature used currently (Table 3) may also 626 
contribute to the perceived complexity of snake venom. We propose that such a nomenclature 627 
system should be based on the comprehensive standards developed for anole lizards (Kusumi 628 
et al., 2011; Hargreaves & Mulley, 2014b). It seems likely that the application of our 629 
approach to other species (together with proteomic studies of extracted venom) will lead to a 630 
commensurate reduction in claimed venom diversity, with clear implications for the 631 
development of next generation antivenoms: since most true venom genes are members of a 632 
relatively small number of gene families, it is likely that a similarly small number of 633 
antibodies may be able to bind to and neutralise the toxic venom components, especially with  634 
the application of “string of beads” techniques (Whitton et al., 1993) utilising fusions of short 635 
oligopeptide epitopes designed to maximise the cross-reactivity of the resulting antibodies 636 
(Wagstaff et al., 2006). 637 
 638 
5. Conclusions 639 
We suggest that identification of the apparently conserved Toxicofera venom toxins in 640 
previous studies is most likely a side effect of incomplete tissue sampling, compounded by 641 
incorrect interpretation of phylogenetic trees and the use of BLAST-based gene identification 642 
methods. It should perhaps not be too surprising that homologous tissues in related species 643 
would show similar gene complements and the restriction of most previous studies to only the 644 
“venom” glands means that monophyletic clades of reptile sequences in phylogenetic trees 645 
have been taken to represent monophyletic clades of venom toxin genes. Whilst it is true that 646 
some of these genes do encode toxic proteins in some species (indeed, this was often the 647 
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basis for their initial discovery) the discovery of orthologous genes in other species does not 648 
necessarily demonstrate shared toxicity. In short, toxicity in one does not equal toxicity in all.  649 
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Tables 1114 
 1115 
Table 1. Predicted venom composition of the painted saw-scaled viper, Echis coloratus 1116 
 1117 
Gene family Number of genes 
SVMP 13 
C-type lectin 8 
Serine protease 6 
PLA2 3 
CRISP 1 
L-amino acid oxidase 1 
VEGF 1 
Crotamine 1 
           Total         8 34 
 1118 
 1119 
 1120 
 1121 
 1122 
 1123 
 1124 
 1125 
 1126 
 1127 
 1128 
 1129 
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Table 2. Predicted numbers of venom toxins and venom toxin families from proteomic studies 1130 
of snake venom accord well with our transcriptome results. 1131 
 1132 
Species Number of 
toxins 
Number of toxin 
families 
Bitis caudalis (Calvete et al., 2007a) 30 8 
Bitis gabonica gabonica (Calvete et 
al., 2006) 
35 12 
Bitis gabonica rhinoceros (Calvete 
et al., 2007a) 
33 11 
Bitis nasicornis (Calvete et al., 
2007a) 
28 9 
Bothriechis schlegelii (Lomonte et 
al., 2008) 
? 7 
Cerastes cerastes (Fahmi et al., 
2012) 
25-30 6 
Crotalus atrox (Calvete et al., 2009) ~24 ~9 
Echis ocellatus (Wagstaff et al., 
2009)  
35 8 
Lachesis muta (Sanz et al., 2008) 24-26 8 
Naja kaouthia (Kulkeaw et al., 
2007) 
61 12 
Ophiophagus hannah (Vonk et al., 
2013) 
? 14 
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Vipera ammodytes (Georgieva et al., 
2008) 
38 9 
 1133 
 1134 
 1135 
 1136 
 1137 
 1138 
 1139 
 1140 
 1141 
 1142 
 1143 
 1144 
 1145 
  1146 
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Table 3. Venom gene nomenclature. Lack of a formal set of nomenclatural rules for venom 1147 
toxins has led to an explosion of different gene names and may have contributed to the 1148 
overestimation of reptile venom diversity. 1149 
Gene/gene family Alternative name and accession number 
3 Finger toxin (3Ftx) Denmotoxin [Q06ZW0] 
Candoxin [AY142323] 
CRISP Piscivorin [AAO62994] 
Catrin [AAO62995] 
Ablomin [AAM45664] 
Tigrin [Q8JGT9] 
Kaouthin [ACH73167, ACH73168] 
Natrin-1 [Q7T1K6] 
CRVP [Q8UW25, Q8UW11] 
Pseudechetoxin [Q8AVA4] 
Pseudechin [Q8AVA3] 
Serotriflin [P0CB15] 
Latisemin [Q8JI38] 
Ophanin [AAO62996] 
Opharin [ACN93671] 
Bc-CRP [ACE73577, ACE73578] 
Ficolin Veficolin [ADK46899] 
Ryncolin [D8VNS7-9, D8VNT0] 
Serine proteases Acubin [CAB46431] 
Gyroxin [B0FXM3] 
Ussurase [AAL48222] 
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Serpentokallikrein [AAG27254] 
Salmobin [AAC61838] 
Batroxobin [AAA48553] 
Nikobin [CBW30778] 
Gloshedobin [POC5B4] 
Gussurobin [Q8UVX1] 
Pallabin [CAA04612] 
Pallase [AAC34898] 
Snake venom metalloproteinase 
(SVMP) 
Stejnihagin-B [ABA40759] 
Bothropasin [AAC61986] 
Atrase B [ADG02948] 
Mocarhagin 1 [AAM51550] 
Scutatease-1 [ABQ01138] 
Austrelease-1 [ABQ01134] 
Vascular endothelial growth factor 
(VEGF) 
Barietin [ACN22038] 
Cratrin [ACN22040] 
Apiscin [ACN22039] 
Vammin [ACN22045] 
Vespryn Ohanin [AAR07992] 
Thaicobrin [P82885] 
Waprin Nawaprin [P60589] 
Porwaprin [B5L5N2] 
Stewaprin [B5G6H3] 
Veswaprin [B5L5P5] 
Notewaprin [B5G6H5] 
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Carwaprin [B5L5P0] 
 1150 
  1151 
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Figure legends 1152 
 1153 
Figure 1. Relationships of key vertebrate lineages and the placement of species 1154 
discussed in this paper. A monophyletic clade of reptiles (which includes birds) is 1155 
boxed and the Toxicofera (Fry et al., 2013) are shaded. Modified taxon names  1156 
have been used for simplicity. Due to the lack of taxonomic resolution within the Colubridae,  1157 
we have placed the term colubrids in inverted commas. 1158 
 1159 
Figure 2. Tissue distribution of proposed venom toxin transcripts. The majority of 1160 
transcripts proposed to encode Toxicoferan venom proteins are expressed in multiple body 1161 
tissues. Transcript order follows descriptions in the main text and those transcripts found in 1162 
the assembled transcriptomes but which are assigned transcript abundance of <1 FPKM are 1163 
shaded orange. VG, venom gland; SAL, salivary gland; SCG, scent gland; SK, skin. 1164 
 1165 
Figure 3. Maximum likelihood tree of complement c3 (“cobra venom factor”) sequences. 1166 
Whilst most sequences likely represent housekeeping or maintenance genes, a gene 1167 
duplication event in the elapid lineage (marked with *) may have produced a venom-specific 1168 
paralog. An additional duplication (marked with +) may have taken place in Austrelaps 1169 
superbus, although both paralogs appear to be expressed in both liver and venom gland. 1170 
Geographic separation in king cobras (Ophiophagus hannah) from Indonesia and China is 1171 
reflected in observed sequence variation. Numbers above branches are Bootstrap values for 1172 
500 replicates. Tissue distribution of transcripts is indicated using the following 1173 
abbreviations: VG, venom gland; SK, skin; SCG, scent gland, AG, accessory gland; VMNO, 1174 
vomeronasal organ and those genes found to be expressed in one or more body tissues are 1175 
shaded blue. 1176 
 1177 
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Figure 4. Maximum likelihood tree of dipeptidylpeptidase 3 (dpp3) and 1178 
dipeptidylpeptidase 4 (dpp4) sequences. Transcripts encoding dpp3 and dpp4 are found in a 1179 
wide variety of body tissues, and likely represent housekeeping genes. Numbers above 1180 
branches are Bootstrap values for 500 replicates. Tissue distribution of transcripts is indicated 1181 
using the following abbreviations: VG, venom gland; SK, skin; SCG, scent gland, AG, 1182 
accessory gland; VMNO, vomeronasal organ and those genes found to be expressed in one or 1183 
more body tissues are shaded blue. 1184 
 1185 
Figure 5. Maximum likelihood tree of phospholipase b (plb) sequences. Transcripts 1186 
encoding plb are found in a wide variety of body tissues, and likely represent housekeeping 1187 
genes. Numbers above branches are Bootstrap values for 500 replicates. Tissue distribution of 1188 
transcripts is indicated using the following abbreviations: VG, venom gland; SK, skin; SCG, 1189 
scent gland, AG, accessory gland; VMNO, vomeronasal organ and those genes found to be 1190 
expressed in one or more body tissues are shaded blue. 1191 
 1192 
Figure 6. Maximum likelihood tree of renin-like sequences. Renin-like genes are 1193 
expressed in a diversity of body tissues. The recently published Boa constrictor “RAP-Boa-1194 
1” sequence is clearly a cathepsin d gene and is therefore not orthologous to the Echis 1195 
ocellatus renin sequence as has been claimed (Fry et al., 2013). Numbers above branches are 1196 
Bootstrap values for 500 replicates. Tissue distribution of transcripts is indicated using the 1197 
following abbreviations: VG, venom gland; SK, skin; SCG, scent gland and those genes 1198 
found to be expressed in one or more body tissues are shaded blue. 1199 
 1200 
Figure 7. Graph of transcript abundance values of proposed venom transcripts in the 1201 
Echis coloratus venom gland. The majority of Toxicoferan transcripts are expressed at 1202 
extremely low level, with the most highly expressed genes falling into only four gene 1203 
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families (C-type lectins, Group IIA phospholipase A2, serine proteases and snake venom 1204 
metalloproteinases). FPKM = Fragments Per Kilobase of exon per Million fragments 1205 
mapped. 1206 
